A quick check of the two Chinese e-commerce platforms shows the H&M stores are already up and running, offering products ranging from women’s wear to household supplies.

Zydus Wellness, an Indian FMCG company, has expanded its Complan brand into the adult nutrition market with the launch of VieMax. Announced today, this move marks the brand’s first venture into ...

Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture its generic version of Paliperidone extended-release tablets, used to treat ...

As per the agreement, CDRI and Zydus will jointly undertake preclinical research, it said. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets, it added ...

In a setback to Swiss multinational pharma company F-Hoffmann-La Roche, the Delhi High Court has dismissed an application filed by the company seeking injunction against Zydus Lifesciences Ltd's ...

Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture Fludrocortisone Acetate Tablets USP, 0.1 mg from the United States Food and Drug ...

Arijit Sengupta has been appointed as Chief Marketing Officer at Zydus Wellness. With more than two decades of executive leadership and international experience in building consumer focused brands ...

On Thursday, Zydus Lifesciences said that the US health agency has given it the go-ahead to start producing its generic version of the schizophrenia treatment drug paliperidone extended-release ...

Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the ...

After a prolonged correction, Zydus Life has formed a hammer pattern on the daily chart, indicating increasing optimism. The RSI is close to being oversold, and the stock has found support at a ...

It has initiated will a 'sell' ratings on Dr Reddys', Lupin Zydus Lifesciences and Auro Pharma with target price of Rs 5,700, Rs 2,250, Rs 850 and Rs 1,333, respectively, suggesting a downside of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...